A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia

NCT05677438 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Androgenetic Alopecia

Interventions

DRUG: CKD-498 dose#1
DRUG: CKD-498 dose#2
DRUG: CKD-498 dose#3
DRUG: Placebo of CKD-498 dose#1
DRUG: Placebo of CKD-498 dose#2
DRUG: Placebo of CKD-498 dose#3

Sponsor

Chong Kun Dang Pharmaceutical